potential

Our European visitors are important to us. This site is currently unavailable to visitors from the European Economic Area while we work to ensure your data is protected in accordance with applicable EU laws.

What may be an effective weapon against the novel coronavirus is coming from an unlikely source: a barn in South Dakota.SAb Biotherapeutics, a South Dakota-based clinical-stage biopharmaceutical company, plans to begin human trials of a COVID-19 antibody treatment using plasma from cows.To do so, scientists genetically engineered the cattle's immune system to produce human antibodies that have the ability to…

Illustration by Peter Hamlin.; What are the potential long-term effects of having COVID-19?It's hard to say exactly, because the coronavirus is still so new that scientists don't know much about long-term effects. The best evidence comes from patients themselves, and some experience a variety of symptoms long after their infections have cleared.Most people recover within…

Early data from a clinical study suggest that an off-label cancer drug provided clinical benefit to a small group of patients with severe COVID-19.The cancer drug acalabrutinib, which blocks the Bruton tyrosine kinase (BTK) protein and is approved to treat some blood cancers, was associated with reduced respiratory distress and a reduction in the overactive…

Published on May 12, 2020According to a report, a coronavirus patient could spend well beyond Rs 3,00,000 on treatment. Is big pharma overcharging for drugs repurposed to treat Covid-10 patients. WION's Palki tells you how 4 researchers found that possible Covid-19 drugs can cost as little as $1. #Gravitas #Coronavirus #Covid19 #CoronavirusAlert #CoronavirusExplained #WionAbout Channel:…